| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |